Literature DB >> 22277569

What (if anything) to do about low-risk prostate cancer.

Chris Parker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22277569     DOI： 10.1016/S0140-6736(12)60066-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors.

Authors:  Takeo Kosaka; Yota Yasumizu; Yasumasa Miyazaki; Akira Miyajima; Eiji Kikuchi; Mototsugu Oya
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

Review 2.  Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?

Authors:  Takeo Kosaka; Akira Miyajima; Mototsugu Oya
Journal:  Front Oncol       Date:  2014-09-16       Impact factor: 6.244

3.  Human castration resistant prostate cancer rather prefer to decreased 5α-reductase activity.

Authors:  Takeo Kosaka; Akira Miyajima; Hirohiko Nagata; Takahiro Maeda; Eiji Kikuchi; Mototsugu Oya
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.